NCT06972680View on ClinicalTrials.gov

Determination of the Optimal Volume of 0.5% Bupivacaine Liposome in Single-Injection Interscalene Brachial Plexus Block: A Bayesian Phase I/II Trial

Enrolling by invitationOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

December 30, 2027

Study Completion Date

December 30, 2027

Conditions
Shoulder Arthroscopy
Interventions
DRUG

Bupivacaine Liposomes(BL)

Prior to surgery, an interscalene brachial plexus block was performed, injecting the preset volume of 0.5% bupivacaine liposomes according to the Bayesian optimal interval method.

Trial Locations (1)

314000

Jiaxing University Affiliated Hospital, Jiaxing

All Listed Sponsors
lead

Affiliated Hospital of Jiaxing University

OTHER